BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3519804)

  • 1. Immunohistological analysis of skin reaction to My1 derived from Mycobacterium leprae.
    Narayanan RB; Ramu G; Malaviya GN; Sinha S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):46-51. PubMed ID: 3519804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ characterization of cells in the dermal infiltrates of lepromin reaction using monoclonal antibodies.
    Narayanan RB; Ramu G; Malaviya GN; Sengupta U; Desikan KV
    Indian J Lepr; 1985; 57(2):265-72. PubMed ID: 3908574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasitism of antigen presenting cells in hyperbacillary leprosy.
    Poulter LW; Collings LA; Tung KS; Waters MF
    Clin Exp Immunol; 1984 Mar; 55(3):611-7. PubMed ID: 6368061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.
    Narayanan RB; Bhutani LK; Sharma AK; Nath I
    Clin Exp Immunol; 1983 Mar; 51(3):421-9. PubMed ID: 6342880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies on dermal granulomas of human leprosy: characterization of cells using monoclonal antibodies.
    Narayanan RB; Girdhar BK; Lavania RK; Sengupta U
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):268-72. PubMed ID: 3088184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
    Samuel NM; Stanford JL; Desikan KV
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OKT6+ epidermal Langerhans' cell numbers in DNCB reactions among leprosy patients.
    Narayanan RB; Girdhar BK; Desikan KV
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):423-6. PubMed ID: 3755743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies.
    Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV
    Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
    Van Voorhis WC; Kaplan G; Sarno EN; Horwitz MA; Steinman RM; Levis WR; Nogueira N; Hair LS; Gattass CR; Arrick BA; Cohn ZA
    N Engl J Med; 1982 Dec; 307(26):1593-7. PubMed ID: 6216407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research.
    Sengupta U; Sinha S
    Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
    Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
    Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
    Klenerman P
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):702-12. PubMed ID: 3123582
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis.
    Roberts PP; Dockrell HM; McAdam KP
    Clin Exp Immunol; 1988 Jun; 72(3):390-3. PubMed ID: 2458870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal changes in reactional leprosy: keratinocyte Ia expression as an indicator of cell-mediated immune responses.
    Thangaraj H; Laal S; Thangaraj I; Nath I
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):401-7. PubMed ID: 2458421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.